Tseng-hui Timothy Chen

2.6k total citations · 2 hit papers
23 papers, 2.0k citations indexed

About

Tseng-hui Timothy Chen is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tseng-hui Timothy Chen has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tseng-hui Timothy Chen's work include CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Spacecraft Design and Technology (4 papers). Tseng-hui Timothy Chen is often cited by papers focused on CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Spacecraft Design and Technology (4 papers). Tseng-hui Timothy Chen collaborates with scholars based in United States, Australia and Japan. Tseng-hui Timothy Chen's co-authors include Alan J. Korman, M. S. Srinivasan, Karla A. Henning, M. J. Selby, Michael Quigley, John Engelhardt, Mark Maurer, Julien Fourcade, Zhaojun Sun and Hong Wang and has published in prestigious journals such as Journal of Clinical Investigation, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Tseng-hui Timothy Chen

23 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

2013 670 citations M. J. Selby, John Engelhardt et al. Cancer Immunology Research profile →
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients

2015 608 citations Joë-Marc Chauvin, Ornella Pagliano et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Tseng-hui Timothy Chen

Since Specialization

Citations

This map shows the geographic impact of Tseng-hui Timothy Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tseng-hui Timothy Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tseng-hui Timothy Chen more than expected).

Fields of papers citing papers by Tseng-hui Timothy Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tseng-hui Timothy Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tseng-hui Timothy Chen. The network helps show where Tseng-hui Timothy Chen may publish in the future.

Co-authorship network of co-authors of Tseng-hui Timothy Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tseng-hui Timothy Chen. A scholar is included among the top collaborators of Tseng-hui Timothy Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tseng-hui Timothy Chen. Tseng-hui Timothy Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager 2022 ·Biochemistry and Biophysics Reports ·(unknown), Patricia Culp, Robert B. DuBridge, Tseng-hui Timothy Chen	3
2	Conditionally active T cell engagers for the treatment of solid tumors: rationale and clinical development 2022 ·Expert Opinion on Biological Therapy ·Tseng-hui Timothy Chen	15
3	Structural arrangement of the VH and VL domains in the COBRA™ T-cell engaging single-chain diabody 2021 ·PubMed ·Jessica Krakow, Michal Hammel, Ying Zhu, Brian J. Hillier, (unknown), (unknown), (unknown), Tseng-hui Timothy Chen, (unknown), (unknown), Robert B. DuBridge, Maia Vinogradova	1
4	COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors 2020 ·mAbs ·(unknown), Pui Seto, Russell Wall, Brian J. Hillier, Ying Zhu, Jessica Krakow, (unknown), (unknown), (unknown), Tseng-hui Timothy Chen, Jeremiah D. Degenhardt, Patricia Culp, (unknown), Maia Vinogradova, Chad May, Robert B. DuBridge	41
5	TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients breakdown → 2015 ·Journal of Clinical Investigation ·Joë-Marc Chauvin, Ornella Pagliano, Julien Fourcade, Zhaojun Sun, Hong Wang, Cindy Sander, John M. Kirkwood, Tseng-hui Timothy Chen, Mark Maurer, Alan J. Korman, Hassane M. Zarour	608
6	Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells breakdown → 2013 ·Cancer Immunology Research ·M. J. Selby, John Engelhardt, Michael Quigley, Karla A. Henning, Tseng-hui Timothy Chen, M. S. Srinivasan, Alan J. Korman	670
7	ISRU Propellant Selection for Space Exploration Vehicles 2013 ·49th AIAA/ASME/SAE/ASEE Joint Propulsion Conference ·Tseng-hui Timothy Chen, (unknown)	4
8	Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors 2009 ·Clinical Cancer Research ·Betty Li, Melinda VanRoey, Changyu Wang, Tseng-hui Timothy Chen, Alan J. Korman, Karin Jooss	153
9	In vitroandIn vivoCharacterization of MDX-1401 for Therapy of Malignant Lymphoma 2009 ·Clinical Cancer Research ·Pina M. Cardarelli, (unknown), (unknown), Amelia Black, David Passmore, Tseng-hui Timothy Chen, (unknown), Jie Liu, Michelle Kuhne, M. S. Srinivasan, Albert Assad, (unknown), Robert F. Graziano, David J. King	21
10	Need for Technology Maturity of Any Advanced Capability to Achieve Better Life Cycle Cost 2009 ·John W. Robinson, (unknown), Ryan E. Rhodes, Tseng-hui Timothy Chen	8
11	Characterization of MDX-1401, a Human Anti-CD30 Antibody with Enhanced Effector Function, for Therapy of Malignant Lymphoma. 2008 ·Blood ·Pina M. Cardarelli, (unknown), (unknown), Amelia Black, David Passmore, Tseng-hui Timothy Chen, (unknown), Jie Liu, Michelle Kuhne, M. S. Srinivasan, Albert Assad, (unknown), Marco Coccia, Robert F. Graziano, David J. King	1
12	RESPONSIVE AIR LAUNCH USING F-15 GLOBAL STRIKE EAGLE 2006 ·Tseng-hui Timothy Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
13	CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. 2003 ·PubMed ·Chin Pan, Pina M. Cardarelli, Matthew Nieder, (unknown), Sanjeev Gangwar, David J. King, Geoffrey Yarranton, (unknown), (unknown), Fengmin Zhou, (unknown), Tseng-hui Timothy Chen, (unknown), Yihong Wang, (unknown), Christopher Bebbington	24
14	CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45 1998 ·Current Biology ·Robert Halenbeck, H. Robson MacDonald, Anne Roulston, Tseng-hui Timothy Chen, Leah Conroy, Lewis T. Williams	182
15	Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. 1996 ·Molecular Biology of the Cell ·Tseng-hui Timothy Chen, Jonathan R. Brody, (unknown), Jun Yu, (unknown), (unknown), Francis P. Kuhajda, Gary R. Pasternack	70
16	pp32 overexpression induces nuclear pleomorphism in rat prostatic carcinoma cells 1996 ·Cell Proliferation ·(unknown), (unknown), Tseng-hui Timothy Chen, (unknown), Francis P. Kuhajda, William C. Dooley, Gary R. Pasternack	7
17	Transfer, expression, and inheritance of salmonid growth hormone genes in channel catfish, Ictalurus punctatus, and effects on performance traits. 1993 ·PubMed ·(unknown), (unknown), (unknown), Mohammad Hayat, Tseng-hui Timothy Chen, Chih‐Ming Lin, Katherine E. Kight, (unknown), Dennis A. Powers	54
18	Chemical identification of catfish growth hormone and prolactin. 1992 ·PubMed ·Kiyotaka Watanabe, Atsuko Igarashi, Toyohiko Noso, Tseng-hui Timothy Chen, Robert A. Durham, Hiroaki Kawauchi	16
19	Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: A pediatric oncology group study 1984 ·Medical and Pediatric Oncology ·Eva Hvizdala, D. H. Berry, Tseng-hui Timothy Chen, Paul G. Dyment, Tae Hyong Kim, C. Philip Steuber, Margaret P. Sullivan	4
20	Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer 1984 ·Journal of Neuro-Oncology ·Theera Umsawasdi, Manuel Valdivieso, Tseng-hui Timothy Chen, H. Thomas Barkley, Daniel J. Booser, Delia F. Chiuten, Hari M. Dhingra, William K. Murphy, (unknown), Peter Farha, Gary Spitzer, David Carr	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact